Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A beta-adrenergic partial agonist (befunolol) discriminates two different affinity sites.

K Koike, I Takayanagi

    Japanese Journal of Pharmacology
    |October 1, 1986
    PubMed
    Summary

    Befunolol, a beta-adrenergic partial agonist, may distinguish between high and low affinity binding sites on the beta-adrenoceptor. This finding offers new insights into beta-adrenoceptor pharmacology and drug interactions.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Characteristics of Ca2+ oscillations in ileal longitudinal muscle cells of guinea pig.

    Japanese journal of pharmacology·2000
    Same author

    Analysis of alpha1-adrenoceptor subtypes in rabbit aorta and arteries: regional difference and co-existence.

    European journal of pharmacology·1999
    Same author

    Differences of antagonism for a selective alpha1D-adrenoceptor antagonist BMY 7378 in the rabbit thoracic aorta and iliac artery.

    Journal of smooth muscle research = Nihon Heikatsukin Gakkai kikanshi·1999
    Same author

    Dimensions of schizophrenic positive symptoms: an exploratory factor analysis investigation.

    European archives of psychiatry and clinical neuroscience·1998
    Same author

    The characteristics of endothelin receptor subtypes on muscle contraction and neuro-transmission in rat vas deferens.

    Biological & pharmaceutical bulletin·1998
    Same author

    Beta-funaltrexamine discriminates between two subtypes of mu2-opioid receptors in electrically stimulated longitudinal muscle of guinea pig ileum.

    General pharmacology·1998

    Area of Science:

    • Pharmacology
    • Adrenergic Receptor Research
    • Biochemistry

    Background:

    • Beta-adrenergic agonists are crucial in regulating physiological processes.
    • Understanding beta-adrenoceptor binding characteristics is key to developing targeted therapies.
    • Partial agonists present complex binding behaviors.

    Purpose of the Study:

    • To investigate the binding interactions of beta-adrenergic partial agonists with the beta-adrenoceptor.
    • To determine if befunolol exhibits differential binding affinities at the beta-adrenoceptor.

    Main Methods:

    • Studied interactions in isolated guinea-pig taenia caecum.
    • Utilized radioligand binding assays with [3H]-befunolol.
    • Analyzed competitive inhibition curves at varying ligand concentrations.

    Related Experiment Videos

    Main Results:

    • Befunolol binding showed a biphasic inhibition curve at high [3H]-befunolol concentration (50 nM), but monophasic at low concentration (1 nM).
    • Isoprenaline and propranolol exhibited monophasic inhibition curves for [3H]-befunolol binding at both concentrations.
    • Differential binding patterns suggest distinct receptor sites.

    Conclusions:

    • Befunolol may discriminate between high and low affinity binding sites on the beta-adrenoceptor.
    • This suggests the existence of at least two distinct binding sites for beta-adrenergic ligands.
    • Findings contribute to the understanding of beta-adrenoceptor heterogeneity.